(Reuters) - The stage is set for more dealmaking in the medical device sector, with companies eager to find faster growth amid a stubbornly weak economy and potential targets still attractively valued.
(Reuters) - The stage is set for more dealmaking in the medical device sector, with companies eager to find faster growth amid a stubbornly weak economy and potential targets still attractively valued.
